Global Hepatitis C Drug Market – Industry Perspective, Comprehensive Analysis, Size, Share, Growth in 2015 – 2021

Global Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application – Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global demand for hepatitis C drug market is expected to reach USD 27.63 billion in 2021



The report covers forecast and analysis for the market on a global and regional level. According to the report, global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, is expected to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% between 2016 and 2021. The study includes drivers and restraints for the hepatitis C drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hepatitis C drug market on a global level.

HCV is a major public health problem that attacks the liver and leads to inflammation. Certain drugs, toxins, heavy alcohol use, bacterial and viral infections can cause hepatitis infection. The most common types of hepatitis infections are Hepatitis A, Hepatitis B, and Hepatitis C and they are caused by three dissimilar dissimilar viruses. Although each virus can cause similar symptoms, they have different modes of transmission and can affect the liver differently. Hepatitis C infection can bring both acute and chronic hepatitis disease. Approximately, 80% of patients get chronically infected with hepatitis C disease. Hepatitis C infection (HCV) spreads through the blood of infected individual by the use of shared needles or supplies used to infuse drugs. Vaccines are available only for Hepatitis A and Hepatitis B viruses. Research into the development of a vaccine for hepatitis C is under way.

The prevalence of the infection, new productive treatments, relatively lesser time of treatment from before, and rising government subsidizing, can drive the hepatitis C drug market. Lack of awareness and information about HCV and treatment expense of disease can influence the hepatitis C market. In the last few years a couple of new drugs have been launched in the market which has huge success and captured maximum market share of the hepatitis C market. However, cost of these drugs is too high. Hospitals, private labs, physician offices, public health labs, and blood banks are the key application of hepatitis C drug market.

In order to give the users of this report a comprehensive view on the hepatitis C market, we have included a detailed competitive scenario and type portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the hepatitis C drug market has also been included. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the hepatitis C drug market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Hospitals, private labs, physician offices, public health labs, and blood banks are the key application of the hepatitis C drug market. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa with its further bifurcation into major countries including U.S., Canada, Germany, France, UK, China, Japan, India and Brazil. This segmentation includes demand for hepatitis C drug based on individual applications in all the regions and countries.

Some of the key player in the hepatitis C drug market includes Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb.

The report segments the global hepatitis C drug market as

Hepatitis C Drug Market: Application Segment Analysis

  • Hospitals
  • Private labs
  • Physician offices
  • Public health labs
  • Blood banks

Hepatitis C Drug Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • Germany
    • UK
    • France
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

  • Chapter 1. Preface
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global hepatitis C drug market, 2015 – 2021, (USD Billion)
    • 2.2. Hepatitis C drug: market snapshot
  • Chapter 3. Hepatitis C Drug Market: Industry Analysis
    • 3.1. Hepatitis C drug : Market dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing incidences of the disease
      • 3.2.2. New efficient therapies and comparatively smaller period of treatment
      • 3.2.3. Rising government funding
    • 3.3. Restraints
      • 3.3.1. Lack of awareness and information about HCV
      • 3.3.2. Treatment cost
      • 3.3.3. Threat related with regulation and development of drug
    • 3.4. Opportunity
      • 3.4.1. Advancing technologies and ongoing research
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by application segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global hepatitis C drug market: Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global hepatitis C drug market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Product Portfolio
    • 4.5. Patent Analysis (2011-2016)
      • 4.5.1. Patent Trend
      • 4.5.2. Patent Share by company
      • 4.5.3. By Region
  • Chapter 5. Global hepatitis C market: Application Overview
    • 5.1. Global hepatitis C drug market share, by application, 2015 and 2021
    • 5.2. Global hepatitis C drug market for hospitals, 2015 – 2021(USD Billion)
    • 5.3. Global hepatitis C drug market for private labs , 2015 – 2021 (USD Billion)
    • 5.4. Global hepatitis C drug market for physician offices, 2015 – 2021 (USD Billion)
    • 5.5. Global hepatitis C drug market for public health labs, 2015 – 2021 (USD Billion)
    • 5.6. Global hepatitis C drug market for blood banks, 2015 – 2021 (USD Billion)
  • Chapter 6. Global hepatitis C drug market: Regional Analysis
    • 6.1. Global hepatitis C drug market: Regional overview
      • 6.1.1. Global hepatitis C drug market share, by region, 2015 and 2021
    • 6.2. North America
      • 6.2.1. North America hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.2.2. U.S.
      • 6.2.3. U.S. hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
    • 6.3. Europe
      • 6.3.1. Europe hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.3.2. UK
        • 6.3.2.1. UK hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.3.3. France
        • 6.3.3.1. France hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.3.4. Germany
        • 6.3.4.1. Germany hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
    • 6.4. Asia Pacific
      • 6.4.1. Asia-Pacific hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.4.2. China
        • 6.4.2.1. China hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.4.3. Japan
        • 6.4.3.1. Japan hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.4.4. India
        • 6.4.4.1. India hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
    • 6.5. Latin America
      • 6.5.1. Latin America hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
    • 6.6. Middle East & Africa
      • 6.6.1. Middle East & Africa hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Merck & Co
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. Kenilworth
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Roche
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Basel Glaxosmith
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Gilead Sciences
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Abbvie
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. Bristol- Myers Squibb.d
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. Johnson & Johnson
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent Developments
  • Chapter 8. Patents
    • 8.1. U.S. (US Patents)
    • 8.2. Europe (EP documents)
    • 8.3. Japan (Abstracts of Japan)
    • 8.4. Global (WIPO (PCT))

List of Tables

1. Global hepatitis C drug market snapshot
2. Drivers for hepatitis C drug market: Impact analysis
3. Restraints of hepatitis C drug market: Impact analysis
4. North America hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
5. U.S. hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
6. Europe hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
7. UK hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
8. France hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
9. Germany hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
10. Asia-Pacific hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
11. China hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
12. Japan hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
13. India hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
14. Latin America hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
15. Brazil hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
16. Middle East & Africa hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)


List of Figures

1. Global hepatitis C drug market segmentation by application, and geography
2. Global hepatitis C drug market, 2015 – 2021 (USD Billion)
3. Porter’s five forces analysis: Hepatitis C drug market
4. Market attractiveness analysis by application segment
5. Market attractiveness analysis by regional segment
6. Global hepatitis C drug market : Company Market Share, 2015
7. Price Trend Analysis : Hepatitis C drug market
8. Patent trend between 2011 -2016
9. Patent Share by Company between 2011 – 2016
10. Patent Share by Region between 2011 – 2016
11. Global hepatitis C drug market share, by application, 2015 -2021
12. Global hepatitis C drug market for hospitals, 2015 – 2021 (USD Billion)
13. Global hepatitis C drug market for private labs, 2015 – 2021 (USD Billion)
14. Global hepatitis C drug market for physician offices, 2015 – 2021 (USD Billion)
15. Global hepatitis C drug market for public health labs, 2015 – 2021(USD Billion)
16. Global hepatitis C drug market for blood banks, 2015 – 2021 (USD Billion)
17. Global hepatitis C drug market share, by region, 2015 – 2021
18. North America hepatitis C drug market, 2015 – 2021, (USD Billion)
19. U.S. hepatitis C drug market, 2015 – 2021, (USD Billion)
20. Europe hepatitis C drug market, 2015 – 2021, (USD Billion)
21. UK hepatitis C drug market, 2015 – 2021, (USD Billion)
22. France hepatitis C drug market, 2015 – 2021, (USD Billion)
23. Germany hepatitis C drug market, 2015 – 2021, (USD Billion)
24. Asia Pacific hepatitis C drug market, 2015 – 2021, (USD Billion)
25. China hepatitis C drug market, 2015 – 2021, (USD Billion)
26. Japan hepatitis C drug market, 2015 – 2021, (USD Billion)
27. India hepatitis C drug market, 2015 – 2021, (USD Billion)
28. Latin America hepatitis C drug market, 2015-2021, (USD Billion)
29. Brazil hepatitis C drug market, 2015 – 2021, (USD Billion)
30. Middle East & Africa hepatitis C drug market, 2015 – 2021, (USD Billion)


Your Name (required)

Your Email (required)

Telephone Number (required)

Name of company (required)

Country Name (required)

How can we help you?

Prove You are Human (required)

captcha
Enter Capcha Image Properly